Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Total Current Liabilities (2021 - 2025)

Rxo's Total Current Liabilities history spans 5 years, with the latest figure at $1.0 billion for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 2.54% year-over-year to $1.0 billion; the TTM value through Dec 2025 reached $1.0 billion, down 2.54%, while the annual FY2025 figure was $1.0 billion, 2.54% down from the prior year.
  • Total Current Liabilities reached $1.0 billion in Q4 2025 per RXO's latest filing, up from $907.0 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $1.1 billion in Q4 2024 to a low of $662.0 million in Q2 2024.
  • Average Total Current Liabilities over 5 years is $839.5 million, with a median of $823.0 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: dropped 18.02% in 2023, then surged 56.16% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $816.0 million in 2021, then rose by 0.86% to $823.0 million in 2022, then dropped by 17.13% to $682.0 million in 2023, then soared by 56.16% to $1.1 billion in 2024, then dropped by 2.54% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for RXO's Total Current Liabilities are $1.0 billion (Q4 2025), $907.0 million (Q3 2025), and $880.0 million (Q2 2025).